Provention Bio, Inc.
Provention Bio, Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.
About Provention Bio, Inc.
Provention Bio, Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by TEPLIZUMAB-MZWV. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: pediatric patients, aged years, onset stage, type diabetes, year age, decline endogenous, insulin production, recently diagnosed. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| TEPLIZUMAB-MZWV | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRAVENOUS | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Provention Bio, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| TZIELD | TEPLIZUMAB-MZWV | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
Frequently asked questions
How many FDA drug products does Provention Bio, Inc. make?
1 FDA drug label records name Provention Bio, Inc. as the manufacturer, covering 1 distinct active ingredients.
What active ingredients does Provention Bio, Inc. produce?
The most frequent active ingredients in this portfolio are TEPLIZUMAB-MZWV.
Are Provention Bio, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.